• Plexus Corp recently reported past fiscal third-quarter 2026 results, delivering record revenue of US$1.30 billion while net income and diluted EPS from continuing operations eased slightly year over year.
• The company also issued fourth-quarter revenue guidance of US$1.33 billion to US$1.38 billion and GAAP diluted EPS of US$2.18 to US$2.34, alongside ongoing share repurchases that modestly reduced its share count.
• We will now examine how this combination of record sales and stronger near-term guidance may influence Plexus’s existing investment narrative.

We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Plexus Investment Narrative Recap

To own Plexus, you need to believe its focus on complex, high value electronics across healthcare, industrial and aerospace can support resilient demand despite program and sector swings. The latest record third quarter revenue of US$1.30 billion and strong fourth quarter guidance reinforce the near term sales momentum, but only modest earnings pressure suggests the key risk remains order volatility and ramp timing in a handful of large customer programs rather than this single quarter’s results.

The most relevant development alongside these results is Plexus’s ongoing share repurchases, with 454,307 shares (1.69% of outstanding) bought back for US$78.61 million under the current program. While the buybacks have only modestly lowered share count so far, they add a supporting factor to earnings per share at a time when revenue is growing quickly but margins are not expanding meaningfully, tying directly into the catalyst of disciplined capital allocation and cash returns.

Yet against this strong revenue print, investors should still be aware of how concentrated customer ramps could quickly magnify any demand setback...

Plexus' narrative projects $6.0 billion revenue and $278.4 million earnings by 2029. This requires 11.8% yearly revenue growth and about a $90.9 million earnings increase from $187.5 million today.

Uncover how Plexus' forecasts yield a $293.25 fair value, a 6% upside to its current price.

Exploring Other Perspectives

Before this update, the most optimistic analysts were banking on revenue near US$6.9 billion and earnings of US$338 million by 2029, so if aerospace and defense wins or facility ramps do not progress as they expect, their bullish story could look very different from the more cautious consensus you might be comparing it with.

Explore 2 other fair value estimates on Plexus - why the stock might be worth as much as 6% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Plexus research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Plexus research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Plexus' overall financial health at a glance.

Contemplating Other Strategies?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Find 52 companies with promising cash flow potential yet trading below their fair value.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 28 companies in the world exploring or producing it. Find the list for free.
• Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.